Target intelligence / Profile preview

Cellular organelles via photodynamic effect

Molecular classification
Other (subcellular structures/organelle targets)
01

Overview

Photodynamic therapy (PDT) is a light-activated treatment that selectively ablates pathological cells (typically cancer) by generating cytotoxic reactive oxygen species in the presence of a photosensitizer. Targeting of cellular organelles—such as mitochondria, lysosomes, endoplasmic reticulum, and the Golgi apparatus—is achieved by delivering photosensitizers that preferentially localize to these compartments. Upon photoactivation, localized oxidative damage leads to cell death via apoptosis or necrosis. Organelle-targeted PDT can enhance therapeutic efficacy and minimize systemic toxicity. While organelle targeting is central to PDT's mechanism, it is not a receptor, enzyme, or protein, but rather a method for inducing cell death in tumors or other pathological tissues. The scientific literature describes ongoing efforts to improve PDT specificity and efficacy by focusing on subcellular targeting strategies.

Other names
Cellular organelles (mitochondria, lysosome, endoplasmic reticulum, Golgi apparatus, etc.)Subcellular compartmentsOrganelle-targeted PDT
02

Mechanism of action

Generation of singlet oxygen and reactive oxygen species following light exposure in the presence of a photosensitizer, leading to oxidative damage and cell death localized at organelles; Activation of intrinsic apoptosis (mitochondrial pathway); Lysosomal membrane permeabilization, leading to release of proteases and apoptosis; Endoplasmic reticulum stress/induction of immunogenic cell death.

03

Biological functions

Cell death (via apoptosis or necrosis induced by photodynamic effect)Signal transduction (secondary to organelle damage and stress pathways)Oxidative stress responseImmune response modulation
04

Disease associations

Cancer (tumor ablation)Infection (antimicrobial PDT)Non-malignant diseases (e.g., psoriasis, age-related macular degeneration)
05

Safety considerations

Off-target phototoxicityLocal tissue damage/inflammationLimited diffusion and short lifespan of reactive oxygen species, resulting in restricted therapeutic windowSkin photosensitivity due to systemic photosensitizer administrationIncomplete tumor ablation leading to recurrence
06

Interacting drugs

Verteporfin (benzoporphyrin derivative)

3 more in the full profile.

07

Biomarkers

Release of cytochrome c (mitochondrial damage/apoptosis)Expression of calreticulin (ER stress/immunogenic cell death)Degradation of DNA (apoptosis)Upregulation of NLRP3 (Golgi apparatus damage)No accepted clinical biomarkers specific to organelle targeting in PDT

Beyond the preview

Go deeper on Cellular organelles via photodynamic effect.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cellular organelles via photodynamic effect.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call